Alizarin Red S

ID: ALA5277614

Max Phase: Preclinical

Molecular Formula: C14H8NNaO7S

Molecular Weight: 335.29

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1c2ccccc2C(=O)c2c1cc(NS(=O)(=O)[O-])c(O)c2O.[Na+]

Standard InChI:  InChI=1S/C14H9NO7S.Na/c16-11-6-3-1-2-4-7(6)12(17)10-8(11)5-9(13(18)14(10)19)15-23(20,21)22;/h1-5,15,18-19H,(H,20,21,22);/q;+1/p-1

Standard InChI Key:  RNIUBLGLQXSMFJ-UHFFFAOYSA-M

Molfile:  

     RDKit          2D

 24 25  0  0  0  0  0  0  0  0999 V2000
    2.9342   -1.4979    0.0000 Na  0  0  0  0  0 15  0  0  0  0  0  0
   -3.2145    0.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4999    0.8245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7881    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7881   -0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4981   -0.8243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2145   -0.4162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0734    0.8251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3587    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3587   -0.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0734   -0.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3539    0.8234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0688    0.4109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0706   -0.4100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3590   -0.8267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0734    1.6503    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0734   -1.6503    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3539    1.6486    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7834    0.8235    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7852   -0.8227    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4999   -0.4100    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2145   -0.8227    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0873    0.3045    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9124    0.3045    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  2  0
  4  3  1  0
  5  4  2  0
  6  5  1  0
  2  7  1  0
  7  6  2  0
  4  8  1  0
  9  8  1  0
 10  9  2  0
 11 10  1  0
  5 11  1  0
  9 12  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 10 15  1  0
  8 16  2  0
 11 17  2  0
 12 18  1  0
 13 19  1  0
 14 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 21 24  2  0
M  CHG  2   1   1  22  -1
M  END

Associated Targets(Human)

PGAM1 Tchem Phosphoglycerate mutase 1 (143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 335.29Molecular Weight (Monoisotopic): 335.0100AlogP: 1.09#Rotatable Bonds: 2
Polar Surface Area: 141.00Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: -1.97CX Basic pKa: CX LogP: 2.10CX LogD: -0.42
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.41Np Likeness Score: 0.59

References

1. Yang GJ, Tao F, Zhong HJ, Yang C, Chen J..  (2022)  Targeting PGAM1 in cancer: An emerging therapeutic opportunity.,  244  [PMID:36215859] [10.1016/j.ejmech.2022.114798]

Source